MedPath

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Completed
Conditions
Influenza Vaccine
Papillomavirus Infection
Pertussis
Registration Number
NCT00828555
Lead Sponsor
Duke University
Brief Summary

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.

SPECIFIC AIMS

1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel \& office staff on their:

* Attitudes towards vaccination of women against preventable diseases

* Perceived barriers to implementing a program to vaccinate women in their offices

* Ideas on how to overcome barriers to successful program implementation

* Current vaccination practices and office-specific administrative processes

2. Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis

3. Determine the effectiveness of the vaccination program based on

* Pre- and post-program vaccination rates

* Program satisfaction amongst Ob/Gyn providers and office staff

* Willingness to continue and possibly extend the program to additional vaccines

4. Quantify the level of support and resources needed to develop and implement the vaccination program

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
3988
Inclusion Criteria
  • 4-5 community Ob/Gyn practices
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis.Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Atrium OBGYN

🇺🇸

Raleigh, North Carolina, United States

Blue Ridge OBGYN

🇺🇸

Raleigh, North Carolina, United States

Westside OBGYN

🇺🇸

Burlington, North Carolina, United States

DWHA

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath